Mechanism Overview: The Hormonal Orchestra That Controls Hair
Hair follicles are exquisitely sensitive to hormonal signals. They express receptors for thyroid hormones, cortisol, estrogen, progesterone, prolactin, and androgens—making them responsive to virtually every major endocrine axis. While the role of androgens in androgenetic alopecia is well-known, the contributions of thyroid dysfunction, cortisol excess, and other hormonal imbalances to hair loss are often underappreciated. Understanding these endocrine connections is essential because hormonal hair loss is often reversible when the underlying endocrine disorder is treated—unlike AGA, which requires ongoing management.
The endocrine system influences hair through both direct and indirect mechanisms. Direct effects occur when hormones bind to receptors on follicular cells and alter gene expression. Indirect effects occur when hormonal changes affect the vascular, immune, or nutritional environment of the follicle. Both mechanisms are relevant to clinical hair loss.
Detailed Mechanism: Thyroid Hormones
Thyroid hormones (T3 and T4) have profound effects on hair follicle biology. Thyroid hormone receptors (TRα and TRβ) are expressed in the outer root sheath, inner root sheath, and dermal papilla of the hair follicle. T3, the active form, directly stimulates keratin gene expression and promotes the transition from telogen to anagen.
Hypothyroidism and hair loss: In hypothyroidism, the reduced availability of T3 leads to prolonged telogen, decreased anagen duration, and impaired keratin synthesis. The result is diffuse hair thinning that can be quite dramatic—up to 30-50% of scalp hair may be in telogen (compared to the normal 10-15%). A study by Heymann (2000), published in the Journal of the American Academy of Dermatology, found that thyroid dysfunction was present in approximately 5-10% of patients presenting with hair loss, making it one of the most common endocrine causes of alopecia.
A study by Verma et al. (2017), published in the Indian Journal of Dermatology, examined 100 patients with hair loss and found that 8% had previously undiagnosed thyroid dysfunction (4% hypothyroid, 4% hyperthyroid). Among those treated for thyroid disease, hair regrowth occurred in 75% within 6 months of achieving euthyroid status.
Hyperthyroidism and hair loss: Less commonly recognized is that hyperthyroidism can also cause hair loss—typically through accelerated hair cycle turnover that increases the proportion of hairs in telogen. The mechanism is different from hypothyroidism: rather than prolonged telogen, hyperthyroidism may cause shortened anagen, leading to increased shedding of shorter hairs.
A study by Schell et al. (2014), published in the Journal of Clinical Endocrinology & Metabolism, demonstrated that T3 directly regulates the expression of hair keratin genes through thyroid hormone response elements (TREs) in their promoters. This provides a direct molecular mechanism by which thyroid hormone deficiency impairs hair shaft production—beyond the general effect on cellular metabolism.
Detailed Mechanism: Cortisol and the Stress-Hormone Axis
Cortisol, the primary glucocorticoid in humans, is produced by the adrenal cortex in response to ACTH from the pituitary gland. Cortisol levels follow a diurnal rhythm (peaking in the morning, nadir at midnight) and are elevated by physical and psychological stress. The hair follicle expresses both glucocorticoid receptor (GR) and mineralocorticoid receptor (MR), and cortisol has well-documented effects on follicle cycling.
Cortisol promotes catagen: In vitro and in vivo studies have demonstrated that cortisol and synthetic glucocorticoids promote the transition from anagen to catagen. A study by Paus et al. (1994), published in the Journal of Investigative Dermatology, showed that glucocorticoid treatment induced catagen in mouse hair follicles, and that this effect was mediated by GR signaling in the follicle epithelium. The downstream mechanism involves cortisol-induced upregulation of TGF-β1, which activates the apoptotic cascade in matrix keratinocytes.
Cortisol impairs stem cell function: A study by Choi et al. (2017), published in Nature, demonstrated that chronic stress (and elevated cortisol) depletes melanocyte stem cells in mouse hair follicles, causing premature hair graying. While this study focused on pigmentation, it raised the possibility that cortisol could also affect epithelial stem cells in the bulge, potentially impairing the regenerative capacity of the follicle.
Cortisol and telogen effluvium: The clinical manifestation of cortisol-induced hair loss is typically telogen effluvium—diffuse shedding that begins 2-3 months after a significant stressor. This timing reflects the duration of the catagen and telogen phases: the stressor triggers premature catagen in anagen follicles, and after the subsequent telogen phase (2-3 months), the telogen hairs are shed. Common triggers include major surgery, severe illness, significant weight loss, and psychological stress.
Detailed Mechanism: Sex Hormones Beyond DHT
Estrogen: Estrogen receptors (ERα and ERβ) are expressed in the hair follicle, particularly in the dermal papilla and outer root sheath. Estrogen generally promotes hair growth: it prolongs anagen, increases the anagen-to-telogen ratio, and may protect against androgen-mediated miniaturization by increasing sex hormone-binding globulin (SHBG), which reduces free testosterone available for conversion to DHT. The decline in estrogen levels during menopause is associated with increased hair thinning in women, consistent with a protective effect of estrogen. A study by Ohnemus et al. (2006), published in the Journal of Investigative Dermatology, demonstrated that 17β-estradiol inhibits catagen development in human hair follicles in vitro through ERβ-mediated signaling.
Prolactin: Prolactin receptors are expressed in the outer root sheath and dermal papilla. Prolactin has been shown to promote catagen and inhibit anagen in mouse models. Hyperprolactinemia (elevated prolactin) is associated with hair loss, and treatment with dopamine agonists (which suppress prolactin) can restore hair growth. A study by Foitzik et al. (2006), published in the American Journal of Pathology, demonstrated that prolactin induces catagen by upregulating TGF-β1 and suppressing VEGF in the follicle.
Progesterone: Progesterone receptors are expressed in the hair follicle, but the effects of progesterone on hair are complex and not fully understood. In vitro, progesterone has been shown to inhibit 5-alpha-reductase activity, potentially reducing local DHT production. However, the clinical significance of this effect is unclear, and the decline in progesterone during menopause (along with estrogen) may remove a protective effect.
Limitations and Clinical Considerations
The primary limitation in the endocrine-hair literature is that most clinical studies are observational and cannot establish causation. The association between thyroid dysfunction and hair loss is proven, but the molecular mechanisms are incompletely characterized beyond the effect of T3 on keratin gene expression. Similarly, while cortisol’s catagen-promoting effects are well-demonstrated in vitro and in animal models, translating this to clinical stress management advice requires caution—not all stress causes hair loss, and not all telogen effluvium is caused by stress.
Another limitation is that hormonal evaluation is not always included in the workup of hair loss patients. The American Academy of Dermatology recommends thyroid function testing for patients with diffuse hair loss, but comprehensive hormonal panels (including cortisol, prolactin, and sex hormones) are not routinely recommended and may not be necessary unless clinical signs suggest an endocrine disorder.
Frequently Asked Questions
Should I get my hormones tested if I have hair loss? If you have diffuse hair shedding, a TSH test is reasonable. Additional hormonal testing (cortisol, prolactin, sex hormones) should be guided by clinical symptoms such as menstrual irregularities, galactorrhea, or signs of Cushing’s syndrome.
Can stress really cause hair loss? Yes, but the relationship is not straightforward. Acute stressors (surgery, illness) are proven triggers for telogen effluvium. Chronic stress may contribute through elevated cortisol, but the evidence for everyday stress causing significant hair loss is less clear.
Does menopause cause hair loss? The decline in estrogen and progesterone during menopause is associated with increased hair thinning in many women. Hormone replacement therapy may help some women, but the risks and benefits must be carefully weighed with a healthcare provider.
Conclusion
Hair follicles are responsive to multiple endocrine signals. Thyroid hormones directly regulate keratin gene expression and anagen maintenance; cortisol promotes catagen through TGF-β1 upregulation and may impair stem cell function; estrogen prolongs anagen and may protect against androgen-mediated miniaturization; and prolactin promotes catagen by suppressing VEGF. The clinical implications are significant: thyroid dysfunction is a common and treatable cause of hair loss, stress-induced cortisol elevation can trigger telogen effluvium, and hormonal changes during menopause contribute to female pattern hair loss. A comprehensive hormonal evaluation should be considered in patients with unexplained diffuse hair shedding, as endocrine causes are often reversible with appropriate treatment.